Search Share Prices
HIK Share Price - What We Learned About Hikma Pharmaceuticals' (LON:HIK) CEO Compensation
Siggi Olafsson became the CEO of Hikma Pharmaceuticals PLC (LON:HIK) in 2018, and we think it's a good time to look ...
Dexrazoxane Market: Global Size, Share, Growth, Overview, Opportunities, Top Leading Company Analysis and Forecast till 2028
Research Nester released a report titled "Dexrazoxane Market: Global Demand Analysis & Opportunity Outlook 2028" which delivers a detailed overview of the global dexrazoxane market in terms of market ...
Hikma Pharma climbs after US court's generic drug ruling
Hikma Pharmaceuticals PLC shares were looking healthier on Friday after a US court ruled in its favour over a generic version of a medicine that currently generates well over US$1 ...
Redde Northgate rises as it acquires UK repair service firm
Mobility solutions group Redde Northgate PLC was a bright spot in late-afternoon trading, rising 7.1% to 204.5p after the firm said it will acquire Nationwide Accident Repair Serv ...
Broker Forecast - Barclays Capital issues a broker note on Hikma Pharmaceuticals PLC
Barclays Capital today upgrades its investment rating on Hikma Pharmaceuticals PLC [LON:HIK] to overweight (from equal weight) and raised its price target to 2800p (from 2350p).